{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:01:29Z","timestamp":1791176489798,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"10","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.molmed.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T17:00:24Z","timestamp":1378141224000},"page":"604-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Nuclear factor kappa B (NF-\u03baB) in multiple sclerosis pathology"],"prefix":"10.1016","volume":"19","author":[{"given":"Conor","family":"Mc Guire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi","family":"Beyaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2013.08.001_bib0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0010","doi-asserted-by":"crossref","first-page":"a001271","DOI":"10.1101\/cshperspect.a001271","article-title":"NF-kappaB in the nervous system","volume":"1","author":"Kaltschmidt","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0015","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.08.001_bib0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00005072-199802000-00008","article-title":"Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions","volume":"57","author":"Gveric","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0035","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9440(10)65456-9","article-title":"Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology","volume":"155","author":"Bonetti","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/brain\/awg107","article-title":"cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity","volume":"126","author":"Mycko","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2013.08.001_bib0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/1531-8249(199909)46:3<425::AID-ANA22>3.0.CO;2-O","article-title":"Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays","volume":"46","author":"Whitney","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.gene.6363846","article-title":"Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations","volume":"3","author":"Miterski","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.molmed.2013.08.001_bib0060","doi-asserted-by":"crossref","first-page":"e8962","DOI":"10.1371\/journal.pone.0008962","article-title":"Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis","volume":"5","author":"Gilli","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2013.08.001_bib0065","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ng.401","article-title":"Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci","volume":"41","author":"De Jager","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2013.08.001_bib0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archneurol.2011.32","article-title":"Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis","volume":"68","author":"Gilli","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.001_bib0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature11307","article-title":"TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis","volume":"488","author":"Gregory","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.001_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2119\/molmed.2010.00071","article-title":"Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells","volume":"17","author":"Lindsey","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1155\/2008\/824640","article-title":"Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-kappaB as a biomarker for relapse of multiple sclerosis","volume":"25","author":"Satoh","year":"2008","journal-title":"Dis. Markers"},{"key":"10.1016\/j.molmed.2013.08.001_bib0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-065X.2012.01106.x","article-title":"NF-kappaB function in B lymphocytes","volume":"246","author":"Kaileh","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2013.08.001_bib0100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.coi.2011.09.003","article-title":"B cells in multiple sclerosis: connecting the dots","volume":"23","author":"von Budingen","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","article-title":"B cells and antibodies in multiple sclerosis pathogenesis and therapy","volume":"8","author":"Krumbholz","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0120","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nri2190","article-title":"The origin and application of experimental autoimmune encephalomyelitis","volume":"7","author":"Baxter","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1084\/jem.20021610","article-title":"Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function","volume":"197","author":"Zheng","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0130","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1101\/gad.9.16.1965","article-title":"Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression","volume":"9","author":"Kontgen","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2013.08.001_bib0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/intimm\/11.3.361","article-title":"c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function","volume":"11","author":"Liou","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI0215254","article-title":"Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation","volume":"110","author":"Hilliard","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.08.001_bib0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.coi.2011.08.005","article-title":"T(H)17 cytokines in autoimmune neuro-inflammation","volume":"23","author":"Becher","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0150","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.1101757","article-title":"The NF-kappaB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis","volume":"187","author":"Chen","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0155","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1084\/jem.20110462","article-title":"The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis","volume":"208","author":"Ruan","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0160","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0170","first-page":"61","article-title":"IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice","volume":"119","author":"Haak","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.08.001_bib0175","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/eji.200838511","article-title":"IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo","volume":"38","author":"Sonderegger","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0180","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.93.8.3405","article-title":"Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor","volume":"93","author":"Gerondakis","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.001_bib0185","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(00)80503-8","article-title":"High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters","volume":"5","author":"Himes","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2013.08.001_bib0190","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1084\/jem.20091411","article-title":"c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells","volume":"206","author":"Isomura","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/eji.200940260","article-title":"c-Rel is crucial for the induction of Foxp3+ regulatory CD4+ T cells but not T(H)17 cells","volume":"40","author":"Visekruna","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0200","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.001_bib0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/376167a0","article-title":"Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B","volume":"376","author":"Beg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.001_bib0210","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.185.5.953","article-title":"NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses","volume":"185","author":"Doi","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0215","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2011.02.019","article-title":"RelA and RelB transcription factors in distinct thymocyte populations control lymphotoxin-dependent interleukin-17 production in gammadelta T cells","volume":"34","author":"Powolny-Budnicka","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2013.08.001_bib0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(00)01167-8","article-title":"Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis","volume":"287","author":"Pahan","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2013.08.001_bib0225","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bbrc.2011.06.195","article-title":"Experimental autoimmune encephalomyelitis: association with mutual regulation of RelA (p65)\/NF-kappaB and phospho-IkappaB in the CNS","volume":"411","author":"Hwang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2013.08.001_bib0230","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI29882","article-title":"Pancreas-specific RelA\/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis","volume":"117","author":"Algul","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.08.001_bib0235","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.4049\/jimmunol.180.4.2588","article-title":"Loss of epithelial RelA results in deregulated intestinal proliferative\/apoptotic homeostasis and susceptibility to inflammation","volume":"180","author":"Steinbrecher","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0240","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.4049\/jimmunol.163.5.2937","article-title":"Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells","volume":"163","author":"Hilliard","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/83158","article-title":"A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation","volume":"2","author":"Das","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0250","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"Jager","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0255","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1172\/JCI22428","article-title":"Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease","volume":"115","author":"O\u2019Donnell","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.08.001_bib0260","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/cr.2010.168","article-title":"Regulation of NF-kappaB signaling by caspases and MALT1 paracaspase","volume":"21","author":"Staal","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.molmed.2013.08.001_bib0265","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0960-9822(03)00491-3","article-title":"Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation","volume":"13","author":"Egawa","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0270","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1074-7613(03)00148-1","article-title":"The MAGUK family protein CARD11 is essential for lymphocyte activation","volume":"18","author":"Hara","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2013.08.001_bib0275","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1126\/science.1090769","article-title":"Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase","volume":"302","author":"Ruefli-Brasse","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molmed.2013.08.001_bib0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(01)00189-1","article-title":"Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure","volume":"104","author":"Ruland","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2013.08.001_bib0285","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1074-7613(03)00293-0","article-title":"Differential requirement for Malt1 in T and B cell antigen receptor signaling","volume":"19","author":"Ruland","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2013.08.001_bib0290","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1172\/JCI63528","article-title":"The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells","volume":"122","author":"Brustle","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.08.001_bib0295","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.4049\/jimmunol.1201351","article-title":"Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination","volume":"190","author":"Mc Guire","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0300","doi-asserted-by":"crossref","first-page":"18529","DOI":"10.1073\/pnas.1204557109","article-title":"T cell receptor\/CARMA1\/NF-kappaB signaling controls T-helper (Th) 17 differentiation","volume":"109","author":"Molinero","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.001_bib0305","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ni1561","article-title":"T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20","volume":"9","author":"Coornaert","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0310","doi-asserted-by":"crossref","first-page":"19946","DOI":"10.1073\/pnas.0907511106","article-title":"Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma","volume":"106","author":"Hailfinger","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.001_bib0315","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0320","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/emboj.2011.85","article-title":"T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1","volume":"30","author":"Staal","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2013.08.001_bib0325","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1073\/pnas.1105020108","article-title":"Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines","volume":"108","author":"Hailfinger","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.001_bib0330","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1074-7613(03)00237-1","article-title":"Mature T cells depend on signaling through the IKK complex","volume":"19","author":"Schmidt-Supprian","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2013.08.001_bib0335","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.173.3.1612","article-title":"I kappa B kinase 2 deficiency in T cells leads to defects in priming, B cell help, germinal center reactions, and homeostatic expansion","volume":"173","author":"Schmidt-Supprian","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0340","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1073\/pnas.0400885101","article-title":"Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation","volume":"101","author":"Schmidt-Supprian","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.001_bib0345","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4049\/jimmunol.179.1.179","article-title":"I kappa B kinase 2\/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis","volume":"179","author":"Greve","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0350","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0092-8674(95)90416-6","article-title":"Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B\/Rel family","volume":"80","author":"Weih","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2013.08.001_bib0355","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.175.4.2102","article-title":"Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation","volume":"175","author":"Corn","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0360","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.20091346","article-title":"Transcriptional regulation of the Th17 immune response by IKK(alpha)","volume":"208","author":"Li","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0365","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.immuni.2010.08.013","article-title":"\u03b3\u03b4 T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism","volume":"33","author":"Petermann","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2013.08.001_bib0370","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4049\/jimmunol.178.3.1341","article-title":"T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity","volume":"178","author":"Gocke","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0375","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2013.08.001_bib0380","doi-asserted-by":"crossref","first-page":"19852","DOI":"10.1074\/jbc.M301945200","article-title":"RelB forms transcriptionally inactive complexes with RelA\/p65","volume":"278","author":"Marienfeld","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2013.08.001_bib0385","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1182\/blood-2008-12-192914","article-title":"Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK","volume":"113","author":"Jin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2013.08.001_bib0390","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.20110128","article-title":"NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses","volume":"208","author":"Hofmann","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0395","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","article-title":"Roles for NF-kappaB in nerve cell survival, plasticity, and disease","volume":"13","author":"Mattson","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2013.08.001_bib0400","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/6458","article-title":"NF-kappaB is activated and promotes cell death in focal cerebral ischemia","volume":"5","author":"Schneider","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2013.08.001_bib0405","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1523\/JNEUROSCI.19-20-08856.1999","article-title":"Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury","volume":"19","author":"Yu","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0410","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1523\/JNEUROSCI.23-28-09403.2003","article-title":"Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection","volume":"23","author":"Fridmacher","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0415","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ni1372","article-title":"Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice","volume":"7","author":"van Loo","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0420","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.4049\/jimmunol.0900834","article-title":"Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system","volume":"183","author":"Emmanouil","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0425","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/brain\/awr203","article-title":"Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB","volume":"134","author":"Taoufik","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2013.08.001_bib0430","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/brain\/awr199","article-title":"Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination","volume":"134","author":"Brambilla","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2013.08.001_bib0435","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2004.02.012","article-title":"TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation","volume":"151","author":"Gimenez","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0440","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.4049\/jimmunol.0802954","article-title":"Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation","volume":"182","author":"Brambilla","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0445","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4049\/jimmunol.180.2.825","article-title":"Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis","volume":"180","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0450","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jaut.2012.02.004","article-title":"Two discreet subsets of CD8 T cells modulate PLP(91\u2013110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice","volume":"38","author":"Mangalam","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molmed.2013.08.001_bib0455","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/eji.200939314","article-title":"Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg","volume":"39","author":"Shi","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0460","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nbd.2012.06.010","article-title":"Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP","volume":"48","author":"Oeckl","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2013.08.001_bib0465","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2012.03.005","article-title":"Neuronal NF-kappaB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination","volume":"246","author":"Lee","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0470","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tcb.2009.05.006","article-title":"The NF-kappaB-independent functions of IKK subunits in immunity and cancer","volume":"19","author":"Chariot","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0475","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/MCB.01065-12","article-title":"IkappaB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400","volume":"32","author":"Roget","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0480","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.4049\/jimmunol.176.10.5788","article-title":"ERK1-\/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis","volume":"176","author":"Agrawal","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0485","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1471-4159.2005.03002.x","article-title":"Extracellular signal-regulated kinase 1\/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo","volume":"93","author":"Pernet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2013.08.001_bib0490","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1523\/JNEUROSCI.0137-12.2012","article-title":"ERK1\/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination","volume":"32","author":"Ishii","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0495","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/brain\/awq359","article-title":"IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system","volume":"134","author":"Raasch","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2013.08.001_bib0500","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-9-15","article-title":"Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation","volume":"9","author":"Ellrichmann","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.molmed.2013.08.001_bib0505","doi-asserted-by":"crossref","first-page":"e9380","DOI":"10.1371\/journal.pone.0009380","article-title":"Myelin activates FAK\/Akt\/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system","volume":"5","author":"Sun","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2013.08.001_bib0510","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1093\/brain\/awn230","article-title":"Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death","volume":"131","author":"Cho","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2013.08.001_bib0515","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1182\/blood-2008-07-168575","article-title":"Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease","volume":"113","author":"King","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2013.08.001_bib0520","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1093\/brain\/awp144","article-title":"CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system","volume":"132","author":"Mildner","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2013.08.001_bib0525","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nn995","article-title":"Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation","volume":"6","author":"Nickols","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0530","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.2483-12.2013","article-title":"Activation of NF-kappaB in Schwann cells is dispensable for myelination in vivo","volume":"33","author":"Morton","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0535","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0540","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1523\/JNEUROSCI.21-18-07046.2001","article-title":"Interleukin-1beta promotes repair of the CNS","volume":"21","author":"Mason","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0545","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/mcne.2000.0883","article-title":"Interferon-gamma protects against cuprizone-induced demyelination","volume":"16","author":"Gao","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.001_bib0550","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.1006301107","article-title":"CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination","volume":"107","author":"Patel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.001_bib0555","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/187152708787122941","article-title":"NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis","volume":"7","author":"Yan","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.molmed.2013.08.001_bib0560","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0565","doi-asserted-by":"crossref","first-page":"e27006","DOI":"10.1371\/journal.pone.0027006","article-title":"Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-kappaB signaling pathways","volume":"6","author":"Jia","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2013.08.001_bib0570","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.4049\/jimmunol.168.12.6506","article-title":"Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase\u2013STAT pathway in T lymphocytes","volume":"168","author":"Natarajan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0575","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/me.2009-0236","article-title":"Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis","volume":"24","author":"van Loo","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0580","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/BF02533841","article-title":"Incidence and severity of experimental allergic encephalomyelitis and cerebral prostaglandin synthesis in essential fatty acid deficient and aspirin-treated rats","volume":"13","author":"Weston","year":"1978","journal-title":"Lipids"},{"key":"10.1016\/j.molmed.2013.08.001_bib0585","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.001_bib0590","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4049\/jimmunol.173.2.1344","article-title":"Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis","volume":"173","author":"Dasgupta","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0595","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2007.03.007","article-title":"Glucocorticoids in the control of neuroinflammation","volume":"275","author":"Tischner","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0600","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1038\/sj.onc.1203218","article-title":"Diverse agents act at multiple levels to inhibit the Rel\/NF-kappaB signal transduction pathway","volume":"18","author":"Epinat","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2013.08.001_bib0605","doi-asserted-by":"crossref","first-page":"19689","DOI":"10.1073\/pnas.1117347108","article-title":"The role of cell type-specific responses in IFN-beta therapy of multiple sclerosis","volume":"108","author":"Zula","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.001_bib0610","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-012-1009-1","article-title":"Reduced astrocytic NF-kappaB activation by laquinimod protects from cuprizone-induced demyelination","volume":"124","author":"Bruck","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2013.08.001_bib0615","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","article-title":"MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo","volume":"22","author":"Fontan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2013.08.001_bib0620","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","article-title":"Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL","volume":"22","author":"Nagel","year":"2012","journal-title":"Cancer Cell"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491413001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491413001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T03:58:26Z","timestamp":1688443106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491413001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":124,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1471491413001330"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2013.08.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear factor kappa B (NF-\u03baB) in multiple sclerosis pathology","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}